Zobrazeno 1 - 10
of 237
pro vyhledávání: '"C. Kaehler"'
Autor:
Dirk Schadendorf, Carola Berking, Lucie Heinzerling, Lisa Zimmer, Ralf Gutzmer, Alexander Kreuter, Andreas Stang, Elisabeth Livingstone, Benjamin Weide, Eleftheria Chorti, Selma Ugurel, Anja Gesierich, Jürgen C Becker, Peter Mohr, Max Schlaak, Patrick Terheyden, Janine Gronewold, Rudolf Herbst, Carmen Loquai, Sarah Knispel, Hildegard Lax, Carsten Weishaupt, Claudia Pföhler, Katharina C Kaehler, Jochen Utikal, Martin Kaatz, Jens Ulrich, Edgar Dippel, Michael Weichenthal
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Background Immune checkpoint inhibition (ICI) is an essential treatment option in melanoma. Its outcome may be improved by a preceding radiation of metastases. This study aimed to investigate the impact of a preceding radiotherapy on the clinical out
Externí odkaz:
https://doaj.org/article/88535c53b95b4637b1aed1641c90cbb3
Autor:
Mirjana Urosevic, Tze-Chiang Meng, Ruth Clark, Stephanie Moosbauer, Katharina C. Kaehler, Jeannine Skalsky, Veronica Tebbs, Dirk Schadendorf, Jean-Jacques Grob, Juergen C. Becker, Axel Hauschild, Reinhard Dummer
Supplementary Table S1 from An Exploratory Study of Systemic Administration of the Toll-like Receptor-7 Agonist 852A in Patients with Refractory Metastatic Melanoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdfc78e095ae18697c3ca713e007eac3
https://doi.org/10.1158/1078-0432.22441153.v1
https://doi.org/10.1158/1078-0432.22441153.v1
Autor:
Mirjana Urosevic, Tze-Chiang Meng, Ruth Clark, Stephanie Moosbauer, Katharina C. Kaehler, Jeannine Skalsky, Veronica Tebbs, Dirk Schadendorf, Jean-Jacques Grob, Juergen C. Becker, Axel Hauschild, Reinhard Dummer
Purpose: A topical Toll-like receptor 7 (TLR7) agonist induces regression of cutaneous melanocytic neoplasms. We explored antitumor activity of a systemically administered TLR7 agonist, 852A, in patients with metastatic melanoma.Experimental Design:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0ca096efff96a7a1ef33a83ff492d44
https://doi.org/10.1158/1078-0432.c.6518293
https://doi.org/10.1158/1078-0432.c.6518293
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Henner Stege, Sara Schneider, Andrea Forschner, Thomas Eigentler, Dorothée Nashan, Svea Huening, Frank Meiss, Saskia Lehr, Martin Kaatz, Robert Kuchen, Katharina C. Kaehler, Maximilian Haist, Jutta Huebner, Carmen Loquai
Publikováno v:
International Journal of Environmental Research and Public Health; Volume 19; Issue 14; Pages: 8365
The global incidence of skin cancer has steadily increased in recent years, and malignant melanoma still has one of the fastest-growing incidence rates among all malignant tumors in the western world. Thus, newly diagnosed patients have an increased
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1821ab4c2c9072420200f983df703854
https://doi.org/10.3390/ijerph19148365
https://doi.org/10.3390/ijerph19148365
Autor:
Caroline J Voskens, Simone M Goldinger, Carmen Loquai, Caroline Robert, Katharina C Kaehler, Carola Berking, Tanja Bergmann, Clemens L Bockmeyer, Thomas Eigentler, Michael Fluck, Claus Garbe, Ralf Gutzmer, Stephan Grabbe, Axel Hauschild, Rüdiger Hein, Gheorghe Hundorfean, Armin Justich, Ullrich Keller, Christina Klein, Christine Mateus, Peter Mohr, Sylvie Paetzold, Imke Satzger, Dirk Schadendorf, Marc Schlaeppi, Gerold Schuler, Beatrice Schuler-Thurner, Uwe Trefzer, Jens Ulrich, Julia Vaubel, Roger von Moos, Patrik Weder, Tabea Wilhelm, Daniela Göppner, Reinhard Dummer, Lucie M Heinzerling
Publikováno v:
PLoS ONE, Vol 8, Iss 1, p e53745 (2013)
Ipilimumab, a cytotoxic T-lymphocyte antigen-4 (CTLA-4) blocking antibody, has been approved for the treatment of metastatic melanoma and induces adverse events (AE) in up to 64% of patients. Treatment algorithms for the management of common ipilimum
Externí odkaz:
https://doaj.org/article/1e9dff99dd604582ac2c2c7a3f9fad75
Autor:
Kerstin Schatton, Lydia Reinhardt, Dirk Schadendorf, Ulrike Keim, Jürgen C. Becker, Nora Schlecht, Andreas Meiwes, Patrick Terheyden, Carmen Loquai, Katharina C. Kaehler, Ulrike Leiter, Claudia Pfoehler, Peter Mohr, Jessica C. Hassel, Selma Ugurel, Elisabeth Livingstone, Cindy Franklin, Ralf Gutzmer, Claus Garbe, Judith Sirokay, David Rafei-Shamsabadi, Michael Weichenthal, Lena Bischof, Lisa Zimmer, Sebastian Haferkamp, Lucie Heinzerling, Albert Rübben, Valerie Glutsch, Thilo Gambichler
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
BackgroundSkin cancers are known for their strong immunogenicity, which may contribute to a high treatment efficacy of immune checkpoint inhibition (ICI). However, a considerable proportion of patients with skin cancer is immuno-compromised by concom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d98eebefd9958b9af88f880d4c2389ae
http://europepmc.org/articles/PMC7583786
http://europepmc.org/articles/PMC7583786
Autor:
Lucie Heinzerling, Elisabeth Livingstone, Eleftheria Chorti, Selma Ugurel, Anja Gesierich, Jürgen C Becker, Peter Mohr, Max Schlaak, Rudolf Herbst, Sarah Knispel, Hildegard Lax, Carsten Weishaupt, Claudia Pföhler, Katharina C Kaehler, Jochen Utikal, Martin Kaatz, Jens Ulrich, Edgar Dippel, Michael Weichenthal
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::51352850e77736ee84bc2c2e66da63e1
https://jitc.bmj.com/content/8/1/e000563corr1.full
https://jitc.bmj.com/content/8/1/e000563corr1.full
Autor:
Johannes Bruns, Esther G.C. Troost, Felix Kiecker, Julia Brütting, Andrea Forschner, Jennifer Linn, Ralf Gutzmer, Katharina C. Kaehler, Jessica C. Hassel, David Rafei-Shamsabadi, Andreas Arnold, Jochen Utikal, Marlene Garzarolli, Lisa Zimmer, Patrik Terheyden, Frank Meiss, Friedegund Meier, Evelyn Dabrowski, Daniel Zips, Steffen Löck, Stefan Beissert, Carola Berking, Fabian Lohaus, Marvin Kuske, Dirk Debus, Dirk Daubner, Ricarda Rauschenberg
Publikováno v:
European Journal of Cancer 110(2019), 11-20
Background Combining stereotactic radiosurgery (SRS) and active systemic therapies (STs) achieved favourable survival outcomes in patients with melanoma brain metastases (MBMs) in retrospective analyses. However, several aspects of this Treatment str
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08d21549e323e683bc9dc791ac25e1b7
https://www.hzdr.de/publications/Publ-28875-1
https://www.hzdr.de/publications/Publ-28875-1